Browsing by Subject "Comorbidity"

20-year trends of characteristics and outcomes of stroke patients with atrial fibrillation

Ntaios G., Sagris D., Gioulekas F., Galanis P., Pardali C., Vemmou A., Koroboki E., Papavasileiou V., Vassilopoulou S., Manios E., Makaritsis K., Spengos K., Mitsikostas D.-D., Milionis H., Vemmos K. (2018)

Background: The accurate knowledge of secular trends in prevalence, characteristics and outcomes of patients with ischemic stroke and atrial fibrillation allows better projections into the future. Aim: We aimed to report ...

2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis

Nikiphorou E., Santos E.J.F., Marques A., Böhm P., Bijlsma J.W.J., Daien C.I., Esbensen B.A., Ferreira R.J.O., Fragoulis G.E., Holmes P., McBain H., Metsios G.S., Moe R.H., Stamm T.A., De Thurah A., Zabalan C., Carmona L., Bosworth A. (2021)

Background: An important but often insufficient aspect of care in people with inflammatory arthritis (IA) is empowering patients to acquire a good understanding of their disease and building their ability to deal effectively ...

Age, Body Mass Index, and Daytime and Nocturnal Hypoxia as Predictors of Hypertension in Patients With Obstructive Sleep Apnea

Natsios G., Pastaka C., Vavougios G., Zarogiannis S.G., Tsolaki V., Dimoulis A., Seitanidis G., Gourgoulianis K.I. (2016)

A growing body of evidence links obstructive sleep apnea (OSA) with hypertension. The authors performed a retrospective cohort study using the University Hospital of Larissa Sleep Apnea Database (1501 patients) to determine ...

Autoantibodies in patients with systemic sclerosis and cancer: A case-control study

Derk, C. T.; Sakkas, L. I.; Rasheed, M.; Artlett, C.; Jimenez, S. A. (2003)

Objective. To determine the prevalence of specific autoantibodies in a cohort of patients with systemic sclerosis (SSc) and a diagnosis of cancer, and to compare it to that in a group of patients with SSc who were never ...

“Blame it on the Comorbidities”: A 5-Year Follow-Up of 53 Chronic Dialysis-Dependent Patients Who Underwent Cardiac Surgery

Deutsch O., Rippinger N., Spiliopoulos K., Eichinger W., Gansera B. (2016)

Objectives This study evaluates midterm survival rates and risk factors for mortality of chronic dialysis-dependent patients undergoing cardiac surgery. Methods Fifty-three dialysis-dependent patients (34 males, aged 67 ± ...

Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial

Kasner S.E., Lavados P., Sharma M., Wang Y., Wang Y., Dávalos A., Shamalov N., Cunha L., Lindgren A., Mikulik R., Arauz A., Lang W., Czlonkowska A., Eckstein J., Gagliardi R., Amarenco P., Ameriso S.F., Tatlisumak T., Veltkamp R., Hankey G.J., Toni D.S., Bereczki D., Uchiyama S., Ntaios G., Yoon B.-W., Brouns R., DeVries Basson M.M., Endres M., Muir K., Bornstein N., Ozturk S., O'Donnell M., Mundl H., Pater C., Weitz J., Peacock W.F., Swaminathan B., Kirsch B., Berkowitz S.D., Peters G., Pare G., Themeles E., Shoamanesh A., Connolly S.J., Hart R.G., NAVIGATE ESUS Steering Committee and Investigators (2018)

Background: The New Approach Rivaroxaban Inhibition of Factor Xa in a Global Trial vs. ASA to Prevent Embolism in Embolic Stroke of Undetermined Source (NAVIGATE-ESUS) trial is a randomized phase-III trial comparing ...

Chronic l-menthol-induced browning of white adipose tissue hypothesis: A putative therapeutic regime for combating obesity and improving metabolic health

Sakellariou P., Valente A., Carrillo A.E., Metsios G.S., Nadolnik L., Jamurtas A.Z., Koutedakis Y., Boguszewski C., Andrade C.M.B., Svensson P.-A., Kawashita N.H., Flouris A.D. (2016)

Introduction: Obesity constitutes a serious global health concern reaching pandemic prevalence rates. The existence of functional brown adipose tissue (BAT) in adult humans has provoked intense research interest in the ...

Co-morbidities in the multiple victims of the silent killer in carbon monoxide poisoning

Mureşan C.-O., Zăvoi R.E., Dumache R.O., Precup C.V., Ciocan V., Bulzan O.Ş., Florou C., Enache A. (2019)

Carbon monoxide (CO) remains an insidious and silent killer due to its physical and chemical properties; its lethal effects are encountered in cases of household accidents, occupational hazards or suicide. Deaths due to ...

Comorbidity, chronic obstructive pulmonary disease, and acute cardiovascular diseases: The Greek experience [Komorbidität, chronische obstruktive Lungenerkrankung und akute Herz-Kreislauf-Erkrankungen: Griechische Erfahrungen]

Papastergiou K., Gourgoulianis K. (2018)

[No abstract available]

Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: A multicenter, case-control study

Panopoulos S., Thomas K., Georgiopoulos G., Boumpas D., Katsiari C., Bertsias G., Drosos A.A., Boki K., Dimitroulas T., Garyfallos A., Papagoras C., Katsimbri P., Tziortziotis A., Adamichou C., Kaltsonoudis E., Argyriou E., Vosvotekas G., Sfikakis P.P., Vassilopoulos D., Tektonidou M.G. (2021)

Objectives: Evidence on comorbidity prevalence in antiphospholipid syndrome (APS) and its difference from high comorbidity burden rheumatic diseases is limited. Herein, we compare multiple comorbidities between APS and RA. ...

Competing mortality in patients with neuroendocrine tumors

Low S.K., Giannis D., Bahaie N.S., Trong B.L.H., Moris D., Huy N.T. (2019)

Objectives: Patients with neuroendocrine tumors (NETs) are at increased risk of mortality from competing causes in light of the improvement in overall survival over recent decades. The purpose of this study was to explore ...

COVID-19 Phenotypes and Comorbidity: A Data-Driven, Pattern Recognition Approach Using National Representative Data from the United States

Vavougios G.D., Stavrou V.T., Konstantatos C., Sinigalias P.-C., Zarogiannis S.G., Kolomvatsos K., Stamoulis G., Gourgoulianis K.I. (2022)

The aim of our study was to determine COVID-19 syndromic phenotypes in a data-driven manner using the survey results based on survey results from Carnegie Mellon University’s Delphi Group. Monthly survey results (>1 million ...

Depression and atherosclerosis

Saleptsis, V. G.; Labropoulos, N.; Halaris, A.; Angelopoulos, N. V.; Giannoukas, A. D. (2011)

The aim of this paper was to examine the interaction between depression and atherosclerosis through a systematic review. A Medline search was performed from 1966 through 2009 using relevant terms such as depression, ...

Determinants of cognitive performance and decline in 20 diverse ethno-regional groups: A COSMIC collaboration cohort study

Lipnicki D.M., Makkar S.R., Crawford J.D., Thalamuthu A., Kochan N.A., Lima-Costa M.F., Castro-Costa E., Ferri C.P., Brayne C., Stephan B., Llibre-Rodriguez J.J., Llibre-Guerra J.J., Valhuerdi-Cepero A.J., Lipton R.B., Katz M.J., Derby C.A., Ritchie K., Ancelin M.-L., Carrière I., Scarmeas N., Yannakoulia M., Hadjigeorgiou G.M., Lam L., Chan W.-C., Fung A., Guaita A., Vaccaro R., Davin A., Kim K.W., Han J.W., Suh S.W., Riedel-Heller S.G., Roehr S., Pabst A., van Boxtel M., Köhler S., Deckers K., Ganguli M., Jacobsen E.P., Hughes T.F., Anstey K.J., Cherbuin N., Haan M.N., Aiello A.E., Dang K., Kumagai S., Chen T., Narazaki K., Ng T.P., Gao Q., Nyunt M.S.Z., Scazufca M., Brodaty H., Numbers K., Trollor J.N., Meguro K., Yamaguchi S., Ishii H., Lobo A., Lopez-Anton R., Santabárbara J., Leung Y., Lo J.W., Popovic G., Sachdev P.S., Cohort Studies of Memory in an International Consortium (COSMIC) (2019)

Background: With no effective treatments for cognitive decline or dementia, improving the evidence base for modifiable risk factors is a research priority. This study investigated associations between risk factors and ...

Effects of varenicline therapy in combination with advanced behavioral support on smoking cessation and quality of life in inpatients with acute exacerbation of COPD, bronchial asthma, or community-acquired pneumonia: A prospective, open-label, preference-based, 52-week, follow-up trial

Politis A., Ioannidis V., Gourgoulianis K.I., Daniil Z., Hatzoglou C. (2018)

Quitting smoking is the most important element in the therapeutic management of chronic respiratory diseases. Combining pharmacotherapy with behavioral support increases smoking cessation success rates. In addition, ...